Global Biologic Drugs Sales Market Report 2021

1 Biologic Drugs Market Overview

• 1.1 Biologic Drugs Product Scope
• 1.2 Biologic Drugs Segment by Type
  • 1.2.1 Global Biologic Drugs Sales by Type (2016 & 2021 & 2027)
  • 1.2.2 Humira
  • 1.2.3 Remicade
  • 1.2.4 Rituxan
  • 1.2.5 Enbrel
  • 1.2.6 Lantus
  • 1.2.7 Avastin
  • 1.2.8 Herceptin
  • 1.2.9 Others
• 1.3 Biologic Drugs Segment by Application
  • 1.3.1 Global Biologic Drugs Sales Comparison by Application (2016 & 2021 & 2027)
  • 1.3.2 Diabetes
  • 1.3.3 Inflammation
  • 1.3.4 Auto-Immune Diseases
  • 1.3.5 Blood Diseases
  • 1.3.6 Cardiovascular Diseases
  • 1.3.7 Others
• 1.4 Biologic Drugs Market Estimates and Forecasts (2016-2027)
  • 1.4.1 Global Biologic Drugs Market Size in Value Growth Rate (2016-2027)
  • 1.4.2 Global Biologic Drugs Market Size in Volume Growth Rate (2016-2027)
  • 1.4.3 Global Biologic Drugs Price Trends (2016-2027)

2 Biologic Drugs Estimates and Forecasts by Region

• 2.1 Global Biologic Drugs Market Size by Region: 2016 VS 2021 VS 2027
• 2.2 Global Biologic Drugs Retrospective Market Scenario by Region (2016-2021)
  • 2.2.1 Global Biologic Drugs Sales Market Share by Region (2016-2021)
  • 2.2.2 Global Biologic Drugs Revenue Market Share by Region (2016-2021)
• 2.3 Global Biologic Drugs Market Estimates and Forecasts by Region (2022-2027)
  • 2.3.1 Global Biologic Drugs Sales Estimates and Forecasts by Region (2022-2027)
  • 2.3.2 Global Biologic Drugs Revenue Forecast by Region (2022-2027)
• 2.4 Geographic Market Analysis: Market Facts & Figures
  • 2.4.1 North America Biologic Drugs Estimates and Projections (2016-2027)
  • 2.4.2 Europe Biologic Drugs Estimates and Projections (2016-2027)
  • 2.4.3 China Biologic Drugs Estimates and Projections (2016-2027)
  • 2.4.4 Japan Biologic Drugs Estimates and Projections (2016-2027)
  • 2.4.5 Southeast Asia Biologic Drugs Estimates and Projections (2016-2027)
  • 2.4.6 India Biologic Drugs Estimates and Projections (2016-2027)

3 Global Biologic Drugs Competition Landscape by Players

• 3.1 Global Top Biologic Drugs Players by Sales (2016-2021)
• 3.2 Global Top Biologic Drugs Players by Revenue (2016-2021)
• 3.3 Global Biologic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biologic Drugs as of 2020)
• 3.4 Global Biologic Drugs Average Price by Company (2016-2021)
• 3.5 Manufacturers Biologic Drugs Manufacturing Sites, Area Served, Product Type
• 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Biologic Drugs Market Size by Type

• 4.1 Global Biologic Drugs Historic Market Review by Type (2016-2021)
  • 4.1.1 Global Biologic Drugs Sales Market Share by Type (2016-2021)
  • 4.1.2 Global Biologic Drugs Revenue Market Share by Type (2016-2021)
  • 4.1.3 Global Biologic Drugs Price by Type (2016-2021)
• 4.2 Global Biologic Drugs Market Estimates and Forecasts by Type (2022-2027)
  • 4.2.1 Global Biologic Drugs Sales Forecast by Type (2022-2027)
  • 4.2.2 Global Biologic Drugs Revenue Forecast by Type (2022-2027)
  • 4.2.3 Global Biologic Drugs Price Forecast by Type (2022-2027)

5 Global Biologic Drugs Market Size by Application

• 5.1 Global Biologic Drugs Historic Market Review by Application (2016-2021)
  • 5.1.1 Global Biologic Drugs Sales Market Share by Application (2016-2021)
  • 5.1.2 Global Biologic Drugs Revenue Market Share by Application (2016-2021)
  • 5.1.3 Global Biologic Drugs Price by Application (2016-2021)
• 5.2 Global Biologic Drugs Market Estimates and Forecasts by Application (2022-2027)
  • 5.2.1 Global Biologic Drugs Sales Forecast by Application (2022-2027)
  • 5.2.2 Global Biologic Drugs Revenue Forecast by Application (2022-2027)
  • 5.2.3 Global Biologic Drugs Price Forecast by Application (2022-2027)

6 North America Biologic Drugs Market Facts & Figures

• 6.1 North America Biologic Drugs Sales by Company
  • 6.1.1 North America Biologic Drugs Sales by Company (2016-2021)
  • 6.1.2 North America Biologic Drugs Revenue by Company (2016-2021)
• 6.2 North America Biologic Drugs Sales Breakdown by Type
  • 6.2.1 North America Biologic Drugs Sales Breakdown by Type (2016-2021)
  • 6.2.2 North America Biologic Drugs Sales Breakdown by Type (2022-2027)
• 6.3 North America Biologic Drugs Sales Breakdown by Application
  • 6.3.1 North America Biologic Drugs Sales Breakdown by Application (2016-2021)
  • 6.3.2 North America Biologic Drugs Sales Breakdown by Application (2022-2027)

7 Europe Biologic Drugs Market Facts & Figures

• 7.1 Europe Biologic Drugs Sales by Company
  • 7.1.1 Europe Biologic Drugs Sales by Company (2016-2021)
  • 7.1.2 Europe Biologic Drugs Revenue by Company (2016-2021)
• 7.2 Europe Biologic Drugs Sales Breakdown by Type
  • 7.2.1 Europe Biologic Drugs Sales Breakdown by Type (2016-2021)
  • 7.2.2 Europe Biologic Drugs Sales Breakdown by Type (2022-2027)
• 7.3 Europe Biologic Drugs Sales Breakdown by Application
  • 7.3.1 Europe 133 Sales Breakdown by Application (2016-2021)
  • 7.3.2 Europe 133 Sales Breakdown by Application (2022-2027)

8 China Biologic Drugs Market Facts & Figures

• 8.1 China Biologic Drugs Sales by Company
  • 8.1.1 China Biologic Drugs Sales by Company (2016-2021)
  • 8.1.2 China Biologic Drugs Revenue by Company (2016-2021)
• 8.2 China Biologic Drugs Sales Breakdown by Type
  • 8.2.1 China Biologic Drugs Sales Breakdown by Type (2016-2021)
  • 8.2.2 China Biologic Drugs Sales Breakdown by Type (2022-2027)
• 8.3 China Biologic Drugs Sales Breakdown by Application
  • 8.3.1 China 156 Sales Breakdown by Application (2016-2021)
  • 8.3.2 China 156 Sales Breakdown by Application (2022-2027)

9 Japan Biologic Drugs Market Facts & Figures

• 9.1 Japan Biologic Drugs Sales by Company
  • 9.1.1 Japan Biologic Drugs Sales by Company (2016-2021)
  • 9.1.2 Japan Biologic Drugs Revenue by Company (2016-2021)
• 9.2 Japan Biologic Drugs Sales Breakdown by Type
  • 9.2.1 Japan Biologic Drugs Sales Breakdown by Type (2016-2021)
  • 9.2.2 Japan Biologic Drugs Sales Breakdown by Type (2022-2027)
• 9.3 Japan Biologic Drugs Sales Breakdown by Application
  • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
  • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Biologic Drugs Market Facts & Figures

• 10.1 Southeast Asia Biologic Drugs Sales by Company
  • 10.1.1 Southeast Asia Biologic Drugs Sales by Company (2016-2021)
  • 10.1.2 Southeast Asia Biologic Drugs Revenue by Company (2016-2021)
• 10.2 Southeast Asia Biologic Drugs Sales Breakdown by Type
  • 10.2.1 Southeast Asia Biologic Drugs Sales Breakdown by Type (2016-2021)
  • 10.2.2 Southeast Asia Biologic Drugs Sales Breakdown by Type (2022-2027)
• 10.3 Southeast Asia Biologic Drugs Sales Breakdown by Application
  • 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
  • 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Biologic Drugs Market Facts & Figures

• 11.1 India Biologic Drugs Sales by Company
  • 11.1.1 India Biologic Drugs Sales by Company (2016-2021)
  • 11.1.2 India Biologic Drugs Revenue by Company (2016-2021)
• 11.2 India Biologic Drugs Sales Breakdown by Type
  • 11.2.1 India Biologic Drugs Sales Breakdown by Type (2016-2021)
  • 11.2.2 India Biologic Drugs Sales Breakdown by Type (2022-2027)
• 11.3 India Biologic Drugs Sales Breakdown by Application
  • 11.3.1 India Biologic Drugs Sales Breakdown by Application (2016-2021)
  • 11.3.2 India Biologic Drugs Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Biologic Drugs Business

• 12.1 Roche
  • 12.1.1 Roche Corporation Information
  • 12.1.2 Roche Business Overview
  • 12.1.3 Roche Biologic Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.1.4 Roche Biologic Drugs Products Offered
  • 12.1.5 Roche Recent Development
• 12.2 Abbott Laboratories
  • 12.2.1 Abbott Laboratories Corporation Information
  • 12.2.2 Abbott Laboratories Business Overview
  • 12.2.3 Abbott Laboratories Biologic Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.2.4 Abbott Laboratories Biologic Drugs Products Offered
  • 12.2.5 Abbott Laboratories Recent Development
• 12.3 Johnson & Johnson
  • 12.3.1 Johnson & Johnson Corporation Information
  • 12.3.2 Johnson & Johnson Business Overview
  • 12.3.3 Johnson & Johnson Biologic Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.3.4 Johnson & Johnson Biologic Drugs Products Offered
  • 12.3.5 Johnson & Johnson Recent Development
• 12.4 Merck & Co.
  • 12.4.1 Merck & Co. Corporation Information
  • 12.4.2 Merck & Co. Business Overview
  • 12.4.3 Merck & Co. Biologic Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.4.4 Merck & Co. Biologic Drugs Products Offered
  • 12.4.5 Merck & Co. Recent Development
• 12.5 Pfizer
  • 12.5.1 Pfizer Corporation Information
  • 12.5.2 Pfizer Business Overview
  • 12.5.3 Pfizer Biologic Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.5.4 Pfizer Biologic Drugs Products Offered
  • 12.5.5 Pfizer Recent Development
• 12.6 Amgen
  • 12.6.1 Amgen Corporation Information
  • 12.6.2 Amgen Business Overview
  • 12.6.3 Amgen Biologic Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.6.4 Amgen Biologic Drugs Products Offered
  • 12.6.5 Amgen Recent Development
• 12.7 Sanofi
  • 12.7.1 Sanofi Corporation Information
  • 12.7.2 Sanofi Business Overview
  • 12.7.3 Sanofi Biologic Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.7.4 Sanofi Biologic Drugs Products Offered
  • 12.7.5 Sanofi Recent Development
• 12.8 Novartis
  • 12.8.1 Novartis Corporation Information
  • 12.8.2 Novartis Business Overview
  • 12.8.3 Novartis Biologic Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.8.4 Novartis Biologic Drugs Products Offered
  • 12.8.5 Novartis Recent Development
• 12.9 Eli Lilly
  • 12.9.1 Eli Lilly Corporation Information
  • 12.9.2 Eli Lilly Business Overview
  • 12.9.3 Eli Lilly Biologic Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.9.4 Eli Lilly Biologic Drugs Products Offered
  • 12.9.5 Eli Lilly Recent Development
• 12.10 Amgen
  • 12.10.1 Amgen Corporation Information
  • 12.10.2 Amgen Business Overview
  • 12.10.3 Amgen Biologic Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.10.4 Amgen Biologic Drugs Products Offered
  • 12.10.5 Amgen Recent Development

13 Biologic Drugs Manufacturing Cost Analysis

• 13.1 Biologic Drugs Key Raw Materials Analysis
  • 13.1.1 Key Raw Materials
  • 13.1.2 Key Raw Materials Price Trend
  • 13.1.3 Key Suppliers of Raw Materials
• 13.2 Proportion of Manufacturing Cost Structure
• 13.3 Manufacturing Process Analysis of Biologic Drugs
• 13.4 Biologic Drugs Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

• 14.1 Marketing Channel
• 14.2 Biologic Drugs Distributors List
• 14.3 Biologic Drugs Customers

15 Market Dynamics

• 15.1 Biologic Drugs Market Trends
• 15.2 Biologic Drugs Drivers
• 15.3 Biologic Drugs Market Challenges
• 15.4 Biologic Drugs Market Restraints

16 Research Findings and Conclusion

17 Appendix

• 17.1 Research Methodology
  • 17.1.1 Methodology/Research Approach
  • 17.1.2 Data Source
• 17.2 Author List